ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 106969 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 106969; 2) Community: the network communities that were significantly associated with the response to NSC 106969; 3) Molecule: the relationships between components within communities and NSC 106969; 4) MDR: the compounds that were significantly associated with the NSC 106969.

NSC Compound Enrichment Correlation
NSC 268665 Null 0.0407060322613564 0.099951311
NSC 309895 Null 0.0407060322613564 0.0996221
NSC 34475 Androst-5-en-16.beta.-ol, 3.beta.-methoxy- (8CI) 0.0407060322613564 0.23862545
NSC 34780 Null 0.0407060322613564 -0.17459775
NSC 348402 Null 0.0407060322613564 0.14245466
NSC 48006 WLN: T6N CNJ DZ EF F- BT5OTJ EO1 0.0407060322613564 0.020361924
NSC 49520 o-Tolualdehyde, 4-(bis(2-chloroethyl)amino)- 0.0407060322613564 -0.20218604
NSC 50273 Pyridine, 3-[[4-[bis(2-chloroethyl)amino]-2-methylbenzylidene]amino]- 0.0407060322613564 -0.079560829
NSC 526333 2,5-Cyclohexadiene-.delta.(1,.alpha.)-acetonitrile, 4-oxo-.alpha.-phenyl-, O-acetyloxime 0.0407060322613564 0.27011714
NSC 606869 Clofarabine 0.0407060322613564 0.023369066
Total:95  Current:87    [First] [Prev] [Next] [Last]